DesmondSchatzMD

PubMed

• Early Appearance of Thyroid Autoimmunity in Children Followed From Birth for Type 1 Diabetes Risk.
  Berglind Jonsdottir, Joanna L Clasen, Kendra Vehik, Åke Lernmark, Markus Lundgren
  The Journal of Clinical Endocrinology and Metabolism. 2025-01-21
• Serological markers of exocrine pancreatic function are differentially informative for distinguishing individuals progressing to type 1 diabetes.
  MacKenzie D Williams, Catherine Ramsey Grace, Amanda L Posgai, Kieran M McGrail, Maigan A Brusko
  BMJ Open Diabetes Research & Care. 2025-01-04
• The impact of the US election on diabetes.
  Irl B Hirsch, Desmond A Schatz
  The Lancet. Diabetes & Endocrinology. 2025-01-01

Journal Articles

• The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update  
  Marian Rewers, Desmond Schatz, William Hagopian, Current Diabetes Reports
• Current and future efforts toward the prevention of type 1 diabetes  
  Schatz DA, Pediatric Diabetes, 1/1/2016
• Puppy love, adolescence, and chronic illness: the importance of pets for youth with type 1 diabetes  
  Walker AF, Schatz DA, Johnson C, Silverstein JH, Rohrs HJ, Journal of patient experience, 1/1/2015
• Heathcare transition from pediatric to adult medical homes in diabetes mellitus  
  Turner JR, Schatz DA, Cusi K, Strumph P, Endocr Pract, 1/1/2014
• Workplace checkup: keeping patients with diabetes employed and safe on the job American Diabetes Association, Diabetes and Employment (Position Statement)  
  Butler K, Schatz D, Hathaway K, Clinical Diabetes, 1/1/2014
• Compromised gut microbiota networks in children with anti-islet cell autoimmunity  
  Endesfelder D, Castell WZ, Ardissone A, Davis-Richardson AG, Achenbach P, Hagen M, Pflueger M, Gano KA, Fagen JR, Drew JC, Brown CT, Kolaczkowski B, Atkinson M, Schatz..., Diabetes, 1/1/2014
• Race, Socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of Type 1 diabetes  
  Lin MH, Connor CG, Ruedy KJ, Beck RW, Kollman C, Buckingham B, Redondo MJ, Schatz D, Haro H, Lee JM, Tamborlane WV, Wood For The Pediatric Diabetes Consortium JR, Diabetes Technol Ther, 1/19/2013
• Effect of a single autologous cord blood infusion on beta cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial  
  Giannopoulou EZ, Puff R, Beyerlein A, von Luettichau I, Boerschmann H, Schatz D, Atkinson M, Haller JM, Egger D, Burdach S, Ziegler AG, Pediatric Diabetes, 1/1/2013
• Framing food and diabetes: exploring the perspectives of youth with type 1 diabetes through photography  
  Walker AF, Schatz DA, Silverstein JH, Parker KA, Aponick AU, Rohrs HJ, SAGE, 1/1/2013
• Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth  
  Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers M, Schatz DA, Krischer JP,  and the TEDDY, TRIGR, Diabetes Prevention Trial-Typ..., Diabetes Care, 1/1/2012
• The Pediatric Diabetes Consortium: improving care of children with type 1 diabetes through collaborative research  
  Schatz DA, Diabetes Technol Ther, 1/1/2010
• Enhancing the understanding of pre-type 1 diabetes in the general population Editorial  
  Simell O., Winter W., Schatz D., Diabetes Care, 1/1/2010
• Hormonization of GAD- and IA-2 autoantibodies assays for NIDDK Consortia  
  Bonifacio E., Yu L., Williams A., Eisenbarth G., Bingley P., Marcinovic S., Koczwara K.,, J Clin Endocinol Metab, 1/1/2010
• Challenges in developing endpoints for type 1 diabetes intervention studies  
  Cernea S., Raz I., Herold K., Hirshberg B., Roep B., Schatz D., Fleming A., Pozzilli P., Little R., Schloot N., Leslie D., Skyler J., Palmer J, Diabetes Metab Res Rev, 1/1/2009
• Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus  
  Gitelman SE, Haller MJ, Schatz DaA, JAMA, 1/1/2009
• Conflicting recommendations for lipid screening and management in children: the need for consensus  
  Rohrs HJ, Schatz DA, Pediatric Consultant, 1/1/2008
• Cardiomyopathy and hypocalcemia: A unified explanation?  
  Horsman TA, Schatz DA, Haller M, Contemporary Pediatrics, 1/1/2008
• Letter in response to : Consensus Statement on the diagnosis and treatment of children with idiopathic short stature: A summary of the Growth Hormone Research Society,...  
  Rosenbloom AL. Guevara-Aguirre J, Haller MJ, Malasanos TH, Miller JL, Rohrs, HJ, Schatz DA, Silverstein JH, Weinstein DA, J Clin Endocrinol Metab, 1/1/2008
• Autologous Umbilical cord blood infusion for Type 1 Diabetes  
  Haller, MJ, HL Viener, C Wasserfal, T Brusko, MA Atkinson, DA Schatz, Exp Hematolo, 1/1/2008
• Persistence of high health care expenditures among children in Medicaid  
  Shenkman E , Knapp C, Sappington D, Vogel B, Schatz D, Med Care Res Rev, 1/1/2007
• Current trials in type 1 diabetes prevention and early intervention: implications for PCPs  
  Rohrs HJ, Schatz DA, Haller MJ, Review of Endocrinology, 1/1/2007
• Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes  
  Haller, MJ and DA Schatz, N. Engl J Med, 1/1/2005
• Effects of oral insulin in relatives of patients with type 1 diabetes mellitus  
  Diabetes Prevention Trial – Type 1 Study Group, Diabetes Care, 1/1/2005
• Type1 diabetes in children and adolescents  
  Haller MJ, Atkinson MA, Schatz DA, Pediatr Clin North America, 1/1/2005
• Obese young girl with acanthosis nigricans and vaginal yeast infection  
  Miller J, M, Schatz D, Pediatric Consultant, 1/1/2003
• Join now to see all

Books/Book Chapters

• Tietz Texbook of Clinical Chemistry and Molecular Diagnostics 
  Chapter: The thyroid gland 
  Winter WE., Schatz DA., Bertholf RLEditors: C Burtis, E Ashwood, D Bruns.Elsevier Saunders, St. Louis, MOEdition 5th,2012
• Annals of the New York Academy of Sciences 
  Chapter: Immunology of Diabetes V. From Bench to Bedside 
  Schatz DAEditors: Sanjeevi CB, Schatz DA, Atkinson MA.2009
• Clinical management of diabetes mellitus: What laboratorians need to know about how diabetes is treated 
  Winter WE, Schatz DA2009
• Pediatric Lipid disorders in clinical practice 
  Rohrs HJ, Schatz D, Winter WE, Davis V2009
• Controversies in treating diabetes: clinical & research aspects 
  Chapter: Childhood diabetes explosion 
  Page 179 - 200Stalvey MS, Schatz DAEditors: LeRoith D, Vinik A.Humana Press2008
• Insulin 
  Chapter: Diabetes tactics 
  Schatz DAEditors: LeRoith D, Edelman SV.2007
• Insulin 
  Chapter: Case Report 
  Page 192 - 193Winter WE, Schatz DAEditors: LeRoith D, Edelman SV.2007
• Insulin 
  Chapter: Case Study 
  Page 192 - 193Winter WE, Schatz DAEditors: Edelman SV, LeRoith D.2007
• Clinical Diabetes 
  Chapter: Genetics and Immunology of Type 1 Diabetes 
  Page 6 - 20Petrovsky N, Winter W, Schatz DAEditors: Fonseca V.Elsevier2006
• Trends in Diabetes Research 
  Chapter: Screening for susceptibility to Type 1 diabetes mellitus 
  Page 71 - 100Haller MJ, Schatz DAEditors: Ashley Ford.Nova Biomedical Books, New York, NY2005
• Pediatric Endocrinology: Mechanisms, Manifestations, and Management 
  Chapter: Genetics of Type 1 diabetes 
  Page 402 - 410Morales A, She J-X, Schatz DAEditors: Pescovitz OH & Eugster E.Lippincott, Williams and Wilkins, Philadelphia, PA2004
• Encyclopedia of Endocrine Diseases 
  Chapter: Type 1 Diabetes 
  Miller J, Winter WE, Schatz DAAcademic Press2004
• Infectious Diseases in Children 
  Chapter: Type 2 diabetes: a growing epidemic in children 
  Schatz DASlack, Inc.2003
• Strategies for the prediction of Type 1 diabetes 
  Haller, MJ, Schatz DA2003
• Distinguishing between type1, type 2, and other forms of diabetes in childhood and adolescence 
  Schatz D, Winter W2003
• Reviews in Endocrine and Metabolic Disorders 
  Chapter: Overview of prevention and intervention trials for type 1 diabetes 
  Page 317 - 323Daaboul J, Schatz DAEditors: Le Roith D, Pietropaolo M.Kluwer Academic Publishers2003
• Pediatric Endocrinology 
  Chapter: Autoimmune Polyglandular Syndromes 
  Page 671 - 688Schatz DA, Winter WEEditors: Mark Sperling.WB Saunders, Philadelphia, PA2002
• Textbook of Diabetes 
  Chapter: Immunology of insulin-dependent diabetes mellitus 
  Petrovsky N, Schatz DAEditors: Williams G, Pickup J.Blackpoole Scientific Press, Liverpool, England2002
• Conn's Textbook of Therapy 
  Chapter: Management of diabetes mellitus in children and adolescents 
  Page 580 - 586Chaudhari M, Schatz DAEditors: Rakel Re, Bope ET.WB Saunders, Philadelphia, PA2001
• Prevention of Type 1 Diabetes 
  Julius M, Schatz DA, Silverstein JH1999
• Endocrinology 
  Chapter: Polyglandular Failure Syndromes 
  Page 3013 - 3024Muir A, Schatz DA, Maclaren NKEditors: DeGroot L.WB Saunders, Philadelphia, PA1994
• Pediatric Annals 
  Chapter: Hypoglycemia in childhood diabetes 
  Schatz DAEditors: Rosenbloom AL.1994
• Pediatric Annals 
  Chapter: Diabetic ketoacidosis in childhood 
  Rosenbloom AL, Schatz DAEditors: Rosenbloom AL.1994
• Proceedings of the New York Academy of Sciences 
  Chapter: Early diagnosis and treatment of insulin dependent diabetes mellitus 
  Maclaren N, Muir A, Silverstein J, Song Y-H, She J-X, Krischer J, Atkinson M, Schatz DEditors: Allison AC, Lafferty KJ, Fliri H.1993
• Endocrinology and Metabolism Clinics of North America 
  Chapter: Pathogenesis, prediction and prevention of Type 1 Diabetes 
  Page 199 - 219Muir A, Schatz DA, Maclaren NKEditors: Karam JH.W.B. Saunders, Philadelphia, PA1992
• Join now to see all

Abstracts/Posters

• HLA-DR and DQ genes confer significant type 1 diabetes (T1D) risk in single autoantibody-positive relatives
  Michels AW, Boulware D, Beam CA, Marks JB, Schatz D, Dimeglio LA, Evans-Molina C, Sosenko JM, Harrison LC, Palmer JP, Greenbaum CJ, Becker DJ, Steck A, Rodrigues H, Go..., ADA 76th Scientific Session, New Orleans, LA, 1/1/2016
• Socioeconomic status and the domestic allocation of Type 1 diabetes care
  Walker AF, Schatz D, Johnson C, Lyles S, Silverstein J, Rohrs H, ADA 76th Scientific Session, New Orleans, LA, 1/1/2016
• Healthecare utilization for publicly insure children with Type 1 Diabetes in Florida and Texas
  Walker AF, Bell RA, Morris HL, Haller MJ, Shuster J, Shenkman B, Sun Y, Schatz D, ADA 76th Scientific Session, New Orleans, LA, 1/1/2016
• Causes of death in the first 100 Type 1 Diabetes (T1D) donors in the network for pancreatic organ donors with diabetes (nPOD
  Jacobsen L, Haller MJ, Kaddis J, Wasserfall C, Levine RS, Campbell-Thompson M, Pugliese A, Atkinson MA, Schatz D, ADA 76th Scientific Session, New Orleans, LA, 1/1/2016
• Type 1 diabetes results in changes in neutrophils, but not neutron-philic enzymes
  Lin A, Haller MJ, Atkinson MA, Mcgrail K, Schatz D, Brantly M, Mathews CE, ADA 76th Scientific Session, New Orleans, LA, 1/1/2016
• Unexpectedly Normal Proinsulin but Low Insulin and c-peptide in the Pancreas of Type 1 Diabetes Subjects
  Wasserfall C, H. Nick, D. Beachy, I. Kusmartseva, T. Heiple, M. Campbell-Thompson, D. Schatz, M. Atkinson, IDS, 1/1/2015
• Reduced relative pancreas weights in organ donors with type 1 and type 2 diabetes
  Campbell-Thompson, M, J.S. Kaddis, C. Wasserfall, M.J. Haller, A. Pugliese, D. Schatz, J.J. Shuster, M.A. Atkinson, IDS, 1/1/2015
• Oral Delivery of a Novel Plant-Derived Insulin and GAD Delays Type 1 Diabetes Onset in NOD Mice
  Posgai A, Wasserfall C, Atkinson M, Schatz D, Daniell H, Diabetes, 1/1/2015
• Short Course Oral Therapy with Plant-Derived Autoantigens Delays Type 1 Diabetes Onset in NOD Mice
  Posgai A, Wasserfall C, Atkinson M, Schatz D, Kwon K, Daniell H, Immunology of Diabetes Society (IDS), 1/1/2015
• Utilizing Oral Combination Therapy with Plant-Expressed Proinsulin, GAD65, and Exendin 4 to Prevent Type 1 Diabetes in NOD Mice
  Posgai A, Wasserfall C, Atkinson M, Schatz D, Kwon K, Daniell H, Immunology of Diabetes Society (IDS), 1/1/2015
• Utilizing Oral Combination Therapy with Plant-Expressed Proinsulin, GAD65, and Exendin 4 to Prevent Type 1 Diabetes in NOD Mice
  Posgai A, Wasserfall C, Atkinson M, Schatz D, Kwon K, Daniell H, Diabetes, 1/1/2015
• Impact of child antibody results on parent anxiety in the environmental determinants of diabetes in the young (TEDDY) study
  Johnson SB, lynch KF, Baxter J, Roth R, Smith LB, Swartling U, Schatz D, The TEDDY Study Group, ADA 75th Scientific Session, Boston, MA, 1/1/2015
• Type 1 diabetes through two lenses: comparing adolescent and parental perspectives with photovoice
  Walker AF, Schatz D, Johnson C, Parker K, Silverstein J, Lyles S, Rohrs H, ADA 75th Scientific Session, Boston, MA, 1/1/2015
• Glucagon nasal powder: an effective alternative to intramuscular glucagon in youth with type 1 diabetes
  Sherr JL, Ruedy KJ, Foster NC, Piche CA, Dulude H, Rickesl MR, Tamborlane WV, Bethin KE, Dimeglio LA, Wadwa P, Fox LA, Schatz DA, Nathan BM, Marconvia SM, Beck RW, ADA 75th Scientific Session, Boston, MA, 1/1/2015
• Is pancreas volume a marker of type 1 diabetes progression? A preliminary report
  Nambam B, Haller MJ, Schatz DA, Shuster JJ, Williams JJ, Beegle R, Cintron M, Ferguson J, Atkinson MA, Campbell-Thompson M, ADA 75th Scientific Session, Boston, MA, 1/1/2015
• GAD autoantibody remission associated with risk of type 1 diabetes: TEDDY study
  Vehik K, Lynch K, Akolkar B, Hagopian WA, Rewers M, She J, Simell OG, Toppari J, Ziegler AG, Lernmark A, Schatz D, Bonifacio E, Krischer JP, The TEDDY study, ADA 75th Scientific Session, Boston, MA, 1/1/2015
• Utilizing oral combination therapy with plant-expressed proinsulin, GAD65, and exendin 4 to prevent type 1 diabetes in NOD mice
  Posgai, A, Wasserfall C, Atkinson MA, Schatz D, Kwon K, Daniell H, ADA 75th Scientific Session, Boston, MA, 1/1/2015
• Development of an educational intervention for fathers of children with diabetes
  Albanese-O’Neill A, Elder JH, Schaffer S, Bernhardt J, Schatz DA, 28th Annual conference of the southern nursing research society, 1/1/2014
• DKA during diabetes therapy: multinational comparison with 59,191 pediatric patients from England, Wales, the United States, Austria and Germany
  Warner JT, Hermann J, Kapellen T, Holl RW, Maahs DM, Dubose S, Schatz D, Beck R, ESPE, Dublin, Ireland, 1/1/2014
• Pump use is less frequent in minority youth: transatlantic analysis in three large registries representing Austria, Germany, England, Wales and the United States
  Rami-Merhar B, Maahs D, Warner J, Hofer S, Tamborlane W, Hermann J, Icks A, Schatz D, Foster N, Holl RW, EASD, 1/1/2014
• Prevention of Type 1 Diabetes in NOD mice with a Subcutaneous Tolerogenic Matrix Containing Insulin
  Yoon YM, Wasserfall C, Lewis J, Haller M, Schatz D, Keselowsky B, Atkinson M, 12th International Immunology of Diabetes Society Conference, Victoria, BC, Canada, 1/1/2014
• Evaluation of knowledge assessment instruments in type 1 diabetes
  Albanese-Oneill Anastasia, Elder, Jennifer, Chaney, Elizabeth H, Schatz, Desmond A, Annual Conference of the Southern Nursing Research Society, 1/1/2013
• The high risk HLA DR4-DQB1*03:02 haplotype is associated with increased progression to T1D in relatives with a single autoantibody specificity
  Pugliese A, Boulware D, Babu S, Marks JB, Schatz DA, Dmeglio L, Harrison LC, Greenbaum C, Becker DJ, Steck AK, Rodriguez H and the Type 1 Diabetes Trialnet Study Group, 73rd ADA Scientific Sessions, Chicago, IL, 1/1/2013
• Framing challenge and resilience in youth with type 1 diabetes: the diabetes photo project
  Walker AF, Schatz DA, Johnson C, Silverstein J, Parker K, Lyles S, Dougherty E, Patrick S, Albanese-O’Neill A, Rohrs H, 73rd ADA Scientific Sessions, Chicago, IL, 1/1/2013
• Oral delivery of a novel plant-derived insulin and GAD delays type 1 diabetes onset in NOD mice
  Posgai A, Wasserfall C, Atkinson M, Schatz D, Daniel H, 73rd ADA Scientific Sessions, Chicago, IL, 1/1/2013
• Join now to see all

Lectures

• Prevention of T1D: Where Are We in 2019? 
  ENDO 2019 - New Orleans, LA - 3/26/2019
• Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association 
  Gainesville, FL - 6/15/2014
• Towards a biological cure of type 1 diabetes: challenges and opportunities 
  Los Angeles, CA - 1/22/2016
• Beginning of end of Type 1 diabetes 
  Ljubljana, Slovenia, 2015; Los Angeles, CA, 2016 - 1/21/2016
• Toward a biological cure of type 1 diabetes: challenges & opportunities 
  Miami, FL - 1/16/2016
• Rationale for new targets in T1D children 
  Keystone, CO - 1/16/2016
• TrialNet ongoing trials: an update 
  Keystone, CO - 1/16/2016
• The environmental determinants of type 1 diabetes (TEDDY) study: what have we learned so far? 
  Miami, FL - 1/15/2016
• Type 1 diabetes is a heterogeneous disease & different in children compared to adults 
  Keystone, CO - 1/15/2016
• Transition of care from adolescence to adulthood: addressing the challenges of patients, families and providers 
  Denver, CO - 1/13/2016
• Diabetes @ 212o Confronting the Invisible Disease 
  New Orleans, LA - 1/12/2016
• Treating to target: are we achieving goals in pediatric patients? 
  Rzeszow, Poland - 1/7/2016
• Prevention & treatment: from probiotics to immunotherapy 
  Orlando, FL - 1/7/2016
• Developing disease modifying therapies in children with type 1 diabetes 
  Milan, Italy - 1/4/2016
• Immune intervention for type 1 diabetes 
  Milan, Italy - 1/4/2016
• The beginning of the end of Type 1 diabetes 
  Multiple locations, 1994, 1995, 1997, 1999, 2000, 2011, 2012, 2016 - 1/1/2016
• Towards the prevention and reversal of type 1 diabetes. What next 
  Chennai, South India - 1/31/2015
• Type 1 diabetes in adolescents target and approach to better management 
  Chennai, South India - 1/31/2015
• T1DM in children & adolescents:treatment goals & quality of care: why is it so difficult to manage? 
  Sao Paulo, Brazil - 1/30/2015
• Medical Devices: The ADA view 
  Paris, France - 1/21/2015
• ADA Standards of Care 
  University of Arizona, Tucson, AZ - 1/14/2015
• Critical questions: How, and at what point? Should type 1 diabetes be diagnosed? 
  1/10/2015
• Why it matters 
  Orlando, FL - 1/9/2015
• Diabetes research in adolecents & young adults-challenges & limitations 
  Kaunas, Lithuania - 1/4/2015
• Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association 
  Gainesville, FL - 6/15/2014
• Join now to see all

Other

• IgG4 antibodies in autoimmune polyglandular disease and IgG4-related endocrinopathies: pathophysiology and clinical characteristics 
  Nambam B, Winter WE, Schatz DA, Curr Opin Pediatr
  1/1/2014
• Autoimmune polyglandular syndromes 
  Haller MJ, Winter WE, Schatz DA
  1/1/2013
• Pediatric lipid disorders in clinical practice.eMedicine from WebMD 
  Rohrs HJ, Schatz D, Winter WE, Davis V
  1/13/2012
• Small steps forward: 2012 update on recent efforts to interdict type 1 diabetes 
  Winter WE, Schatz DA, American Academy of Pediatrics Endo Newsletter
  1/1/2012
• Tracking obesity 
  Schatz DA, CADRE
  1/1/2011
• Autoimmune markers in diabetes 
  Winter W., Schatz D., Clinical Chemistry
  1/1/2011
• Laboratory support for diabetes testing certificate program 
  Winter WE., Schatz D., AACC Diabetes certificate program
  http://aacc.org/events/online_progs/certificates/diabetes/pages/default.aspx
  1/1/2009
• Interpretation of the oral glucose tolerance test 
  Rohrs HJ, Schatz DA, Diabetes Self-Management
  1/1/2009
• Pediatric lipid disorder in clinical practice 
  Rohrs H., Schatz D., Winter W., Davis V.
  http://www.emedicine.com/ped/TOPIC2787.HTM
  1/23/2008
• The environmental determinants of diabetes in the young (TEDDY) Study 
  TEDDY Study Group, Immunology of Diabetes V: Ann NY Acad Sci
  1/1/2008
• Exendin-4 therapy in new onset NOD mice increases regulatory T cell frequency 
  Xue S, Wasserfall CH, Parker M, Brusko TM, McGrail S, McGrail K, Moore M, Campbell-Thompson M, Schatz DA, Atkinson MA, Haller MJ
  1/1/2008
• Ped Pediatric lipid disorders in clinical practice 
  Rohrs HJ, Schatz DA, Winter WE, Davis V, eMedicine
  http://www.emedicine.com/ped/topic2787.htm
  1/1/2008
• Treatment plans for adolescent type 2 diabetes 
  Schatz DA, CADRE Current Diabetes Practice
  1/1/2005
• Neonatal nutritional interventions in the prevention of Type 1 diabetes 
  Caicedo RA, Li N, Atkinson MA, Schatz DA, Neu J, NeoReviews
  1/1/2005
• How to manage insulin resistance in children 
  Haller MJ, Schatz DA, Consultant
  1/1/2005
• Diabetes screening in children: when and how 
  Haller MJ, Schatz DA, Consultant
  1/1/2004
• Status of neonatal risk assessment for type 1 diabetes? 
  Schatz DA, Winter WE, Medscape Diabetes & Endocrinology
  http://www.medscape.com/viewarticle/463393
  1/1/2003
• Benefits of Type1 diabetes screening 
  Schatz DA, Advances for Medical Laboratory Professionals
  1/1/2003
• Glucose dose in oral glucose tolerance testing of obese patients 
  Winter WE, Schatz DA, Medscape Diabetes & Endocrinology
  http://www.medscape.com/viewarticle/449860
  1/1/2003
• Performing an oral glucose tolerance test in a pregnant woman with severe emesis 
  Winter WE, Schatz DA, Medscape Diabetes & Endocrinology
  http://www.medscape.com/viewarticle/449869
  1/1/2003
• Role of the oral glucose tolerance test (OGTT) in the diagnosis and management of diabetes mellitus 
  Winter WE, Schatz DA, Medscape Diabetes & Endocrinology
  http://www.medscape.com/viewarticle/448038
  1/1/2003
• What have been the outcomes from type 1 diabetes prevention trials? 
  Schatz DA, Winter WE, Medscape Diabetes & Endocrinology
  medscape.com/viewarticle/436017?srcmp=endo-062102
  1/1/2003
• Will Vitamin D Supplementation to reverse the rising incidence of type 1 diabetes? Editorial 
  Schatz DA, Silverstein JH, AAP Newletter
  1/1/2002
• Characteristics of atypical diabetes mellitus 
  Winter WE, Schatz DA
  http://www.medscape.com/viewarticle/412403
  1/1/2002
• Autoimmune Polyglandular Syndrome II: Clinical Syndrome and Therapy 
  Schatz DA, Winter WE, Endocrinol Metab Clin North Am
  1/1/2002
• Join now to see all